Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles

By Li T.-C.   Suzaki Y.   Ami Y.   Dhole T.N.   Miyamura T.   Takeda N.  

Vaccine, Vol. 22, Iss. 3, 2004-01 ,pp. : 370-377

Elsevier

Access to resources Recommend Favorite

Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen

By Londono L.P.   Chatfield S.   Tindle R.W.   Herd K.   Xiao-Ming G.   Frazer I.   Dougan G.  

Vaccine, Vol. 14, Iss. 6, 1996-04 ,pp. : 545-552

Elsevier

Access to resources Recommend Favorite

Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection

By Huisman W.   Karlas J.A.   Siebelink K.H.J.   Huisman R.C.   de Ronde A.   Francis M.J.   Rimmelzwaan G.F.   Osterhaus A.D.M.E.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 181-187

Elsevier

Access to resources Recommend Favorite

The relation between anti-hepatitis A virus antibodies and residence water access in Rio de Janeiro, Brazil

By Luiz Ronir R.   Almeida Renan M. V. R.   Almeida Rosimary T.   de Almeida Liz Maria  

International Journal of Hygiene and Environmental Health, Vol. 206, Iss. 6, 2003-10 ,pp. : 575-582

Urban & Fischer

Access to resources Recommend Favorite

Induction of antibodies against structural proteins of hepatitis C virus in mice using recombinant adenovirus

By Makimura M.   Miyake S.   Akino N.   Takamori K.   Matsuura Y.   Miyamura T.   Saito I.  

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 28-34

Elsevier

Access to resources Recommend Favorite